Lanfan Medical (002382.SZ) announced semi-annual results, with net profit of 95.689 million yuan to mother, turning a year-on-year loss into a profit

According to Zhitong Finance App News, Lanfan Healthcare (002382.SZ) released its 2026 semi-annual report. During the reporting period, the company achieved operating income of 3.705 billion yuan, an increase of 29.67%; net profit attributable to shareholders of listed companies was 956.789 million yuan, turning a year-on-year profit into a profit; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 797.228 million yuan, turning a year-on-year loss into profit; basic earnings per share were 0.1 yuan.

During the reporting period, all of the company's divisions achieved profits in the first half of 2026. Among them: the company's health protection division actually reversed losses and achieved net profit of 266 million yuan despite exchange losses, operating income increased by about 36% over the same period last year, and gross margin increased significantly; the performance performance of the gloves business was significantly repaired by various measures such as supplementary heat and power generation energy support, production line technology improvement and efficiency improvement, etc., as well as the combined effects of rising glove order prices and phased price advantages of early strategic procurement of raw materials; the business performance of the company's cardiovascular division continued to improve. After reversing losses in 2025, net profit of 90 million yuan was achieved in the first half of 2026, a further increase of about 12% over the same period last year; due to the division's minority shareholders, the total net profit attributable to shareholders of listed companies was about 250 million yuan.

In the first half of 2026, the company headquarters also covered expenses other than the division. Among them, the cardiovascular division continued to accrue about 50 million yuan in round A financing repurchase interest, about 24 million yuan of “Blue Sail Bonds” interest due in the current accounting, additional exchange losses on assets related to the company headquarters, and other interest expenses, management expenses, etc. at the headquarters level. In total, the negative impact on net profit attributable to shareholders of the listed company was about 150 million yuan, so that the company achieved a net profit of about 100 million yuan attributable to listed shareholder companies during the reporting period.